Bio-Rad Laboratories makes life-science research instruments and reagents and clinical-diagnostic systems used in laboratories and hospitals.
| Filer | 13FScore | This quarter | Shares | Value | % of their book |
|---|---|---|---|---|---|
| David Einhorn / Greenlight | 45 | New buy | 103,990 | $39,278,063 | 1.1% |
| Bridgewater | 55 | New buy | 749 | $282,905 | 0.0% |
| Paul Tudor Jones / Tudor | 61 | Trimmed -83% | 4,284 | $1,618,110 | 0.0% |
Every tracked holder of this name, sorted new → added → flat → trimmed. Shares = reported 13F share count; Value as reported (a few managers file values in $thousands). Generated 2026-11-17.